Twisted Amide‐Mediated Synthesis and Rapid Structure‐Activity Relationship Study of Medium‐Sized Cyclic Peptides
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202500331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Takefumi Kuranaga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of System Chemotherapy and Molecular Sciences, Division of Medicinal Frontier Sciences, Graduate School of Pharmaceutical Sciences, Kyoto …. Hauptthemen laut MEDLINE: Peptides, Cyclic, Amides, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, the Japan Agency for Medical Research and Development (AMED), Japan, Takeda Science Foundation.
Abstract (Originalsprache)
Medium‐sized cyclic peptides are expected to be ideal drug leads because these peptides combine the advantages, while compensating for the disadvantages, of small molecules and antibodies. Although medium‐sized peptides can be produced by chemical synthesis, two major problems, namely (i) Cα‐epimerization during C ‐terminal modification and (ii) side reactions in the cyclization, remain to be solved. These issues have hampered the synthesis of pure materials for bioassays, making it difficult to accomplish accurate structure‐activity relationship (SAR) studies. Herein, we report an efficient synthesis of medium‐sized cyclic peptides based on the twisted amide‐mediated amidation strategy. First, a variety of linear peptides were synthesized by the “inverse” peptide synthesis and fragment coupling. Second, the C ‐terminus of the linear peptides were converted to twisted amides, which were then reacted with a variety of α‐amino acyl sulfonamides, realizing the rapid C ‐terminal diversification of peptides. Finally, the resulting linear peptides were cyclized by the intramolecular twisted amide‐mediated amidation to afford stereochemically pure cyclic peptides. Using this strategy, total synthesis of acyl‐surugamide A, the stereoselective synthesis of 13 non‐natural analogs, and the discovery of potent antimicrobial/antifungal peptides beyond the natural product were also achieved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of System Chemotherapy and Molecular Sciences, Division of Medicinal Frontier Sciences, Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida, Sakyo-ku, Kyoto, 606-8501, Japan.
ORCID-Profile: Takefumi Kuranaga, Hideaki Kakeya
Förderung
- the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan
- the Japan Agency for Medical Research and Development (AMED), Japan
- Takeda Science Foundation
- Tokyo Biochemical Research Foundation
- the foundation of Tokyo Chemical Industry
Zitieren
APA
Kuranaga, T., Koyama, A., Asano, J., Matsumoto, T., & Kakeya, H. (2025). Twisted Amide‐Mediated Synthesis and Rapid Structure‐Activity Relationship Study of Medium‐Sized Cyclic Peptides. Chemistry – A European Journal. https://doi.org/10.1002/chem.202500331
Vancouver
Kuranaga T, Koyama A, Asano J, Matsumoto T, Kakeya H. Twisted Amide‐Mediated Synthesis and Rapid Structure‐Activity Relationship Study of Medium‐Sized Cyclic Peptides. Chemistry – A European Journal. 2025. doi:10.1002/chem.202500331
BibTeX
@article{Kuranaga2025,
author = {Kuranaga, Takefumi and Koyama, Ai and Asano, Junta and Matsumoto, Takumi and Kakeya, Hideaki},
title = {Twisted Amide‐Mediated Synthesis and Rapid Structure‐Activity Relationship Study of Medium‐Sized Cyclic Peptides},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202500331}
}
EUVIMED